May 30, 2025 | ATTR
2) #Transthyretin #Amyloid (#ATTR) #Cardiomyopathy (#ATTR_CM) is now known to be underdiagnosed & much more common than we once thought. With now 3 @US_FDA approved treatments for ATTR-CM, let's go back to the basics & re-educate ourselves on this...
Apr 28, 2025 | ATTR
2) This was a busy #ACC25 with numerous updated datasets and analyses focusing on #ATTR #CM targeted therapies. @MasriAhmadMD will cover certain selected presentations.BTW for foundational education on #ATTR_CM & #ATTR_PN see https://t.co/41keu1Y9kb...
Mar 4, 2024 | ATTR
1b) We are honoured to have as our guest expert faculty Fausto Pinto MD PhD @fjpinto1960, Diretor do Serviço de Cardiologia do @ulssanta_maria; Past-President, #WHF, Past-President @escardio, from Lisbon ??. As you might have noticed ⤴️, he is the senior author of...
Feb 19, 2024 | ATTR
2) Our expert first-time @cardiomet_ve author is Dra. Lucía Galán Dávila @lucia_galan, Especialista de área Neurologiaat Hospital Clinico San Carlos de Madrid ??! @IIS_IdISSC#neurotwitter #attrpn #amyloidosis pic.twitter.com/kpAgVCtVZe— cardio-met...
Nov 14, 2023 | ATTR
2) Follow this ?to earn 0.5hr CE/#CME. This program is intended for #healthcare providers. Statement of accreditation & faculty disclosures at https://t.co/gvXca4G9Xm. This program supported by an independent educational grant from AstraZeneca.#MedEd...
Oct 23, 2023 | ATTR
2) Our expert author is Ronald Witteles MD @Ron_Witteles, @StanfordMed IM program director, Professor of Medicine, #Cardiologist, Specialist in #Amyloidosis, #Sarcoidosis, #Cardio_Oncology, and Advanced #heartfailure . . . and he's ?ing this program at...